60例冠心病心绞痛患者的临床治疗研究

目的 探讨倍他乐克联合通心络胶囊在治疗冠心病心绞痛中的应用价值.方法 将2012年7月至2013年3月收治的60例冠心病心绞痛患者按不同治疗方式随机均分为对照组（常规治疗＋通心络）和实验组（常规治疗＋通心络＋倍他乐克）,治疗3个月后比较两组患者临床症状及心电图改善情况.结果 实验组患者心绞痛症状改善总有效率达到86.7％,与对照组（60.0％）比较差异有统计学意义（P＜0.05）；实验组患者心电图改善有效率达到80.0％,明显高于对照组（63.3％）（P＜0.05）；治疗3个月后,实验组患者硝酸甘油的每天用量明显少于对照组患者（P＜0.05）.结论 倍他乐克联合通心络胶囊治疗冠心病心绞痛效果显著,症状改善明显,值得临床推广应用.

Clinical study on the treatment of 60 cases patients with coronary heart disease and angina

Objective To investigate the application of Betaloc combined with Tongxinluo in treating coronary heart disease with angina.Methods 60 cases of coronary heart disease with angina in our hospital from July 2012 to March 2013 were divided into control group （Tongxinluo） and experimental group （Tongxinluo＋Betaloc）,the efficacy of two groups were compared after 3 months.Results The total effective rate of angina pectoris in experimental group was 86.7％,which was higher than that in control group （P ＜ 0.05）; the total effective rate of electrocardiogram amelioration in experimental group was higher than that in control group （P ＜ 0.05）; the amount of nitroglycerin in experimental group was lower than that in control group （P ＜ 0.05）.Conclusion Betaloc combined with Tongxinluo has significant effects in treating coronary heart disease with angina,which was worthy of clinical promotion.